Empty Bowls fundraiser at Binghamton General tomorrow
BINGHAMTON, NY (WIVT/WBGH) – There was a fundraiser at UHS this afternoon, where people got a quality lunch and take home a handcrafted bowl, all for a good cause.
This afternoon marked the 19th annual Empty Bowls lunch event.
The public was invited to UHS Medical Center in Johnson City for a catered lunch of pasta, soups, burgers, desserts and more, to raise money for the Food Bank of the Southern Tier.
Those who attended also got to select a handcrafted bowl of their choice, as a keepsake, and reminder of food insecurity in our community.
The Corporate Partnerships Manager at the Food Bank, Maddy McClenahan, says if you missed out today, there will be another lunch event at Binghamton General, tomorrow from 11:30 to 1:30.
'It's a great opportunity to connect with people who care about food insecurity and food brings people together. So, it's just a great way to get together over some delicious food, meet new people, and do good,' says McClenahan.
Tickets for tomorrow's event are $25 and a portion of the funds raised will support the UHS Foundation's STOP Hunger Fund and the Food Bank.
You can purchase tickets at NYUHS.org/events.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 hours ago
- Yahoo
Why Universal Health Services (UHS) Shares Are Trading Lower Today
Shares of hospital management company Universal Health Services (NYSE:UHS) fell 5.7% in the afternoon session after Chief Financial Officer Steve Filton noted during a recent conference that procedural volumes (an important driver of hospital revenue) "have been slower to recover back to historical levels than we might have imagined." Filton also voiced concern over the Trump administration's proposed federal spending bill, particularly its implications for healthcare funding. Since UHS derives a significant portion of its revenue from government programs like Medicare and Medicaid, the anticipated cuts to Medicaid could significantly affect the company, especially in regions with high dependency on public healthcare funding. The shares closed the day at $177.76, down 6.2% from previous close. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Universal Health Services? Access our full analysis report here, it's free. Universal Health Services's shares are not very volatile and have only had 8 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business. The previous big move we wrote about was 28 days ago when the stock gained 5.9% after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides agreed to pause some tariffs for 90 days, signaling a potential turning point in ongoing tensions. This rollback cuts U.S. tariffs on Chinese goods to 30% and Chinese tariffs on U.S. imports to 10%, giving companies breathing room to reset inventories and supply chains. However, President Trump clarified that tariffs could go "substantially higher" if a full deal with China wasn't reached during the 90-day pause, but not all the way back to the previous levels. Still, the agreement has cooled fears of a prolonged trade war, helping stabilize expectations for global growth and trade flows and fueling renewed optimism. The optimism appeared concentrated in key trade-sensitive sectors, particularly technology, retail, and industrials, as lower tariffs reduce cost pressures and restore cross-border demand. Universal Health Services is down 1.1% since the beginning of the year, and at $177.77 per share, it is trading 26.4% below its 52-week high of $241.52 from September 2024. Investors who bought $1,000 worth of Universal Health Services's shares 5 years ago would now be looking at an investment worth $1,628. Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
14 hours ago
- Yahoo
3 Healthcare Stocks in Hot Water
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry's returns - over the past six months, healthcare stocks have collectively shed 12.3%. This drawdown was noticeably worse than the S&P 500's 1.9% loss. Investors should tread carefully as the influx of venture capital has also ushered in a new wave of competition. Keeping that in mind, here are three healthcare stocks we're swiping left on. Market Cap: $12.17 billion With a network spanning 39 states and three countries, Universal Health Services (NYSE:UHS) operates acute care hospitals and behavioral health facilities across the United States, United Kingdom, and Puerto Rico. Why Are We Hesitant About UHS? Poor comparable store sales performance over the past two years indicates it's having trouble bringing new patients into its facilities Expenses have increased as a percentage of revenue over the last five years as its adjusted operating margin fell by 1.2 percentage points Free cash flow margin shrank by 3.1 percentage points over the last five years, suggesting the company is consuming more capital to stay competitive Universal Health Services's stock price of $188.81 implies a valuation ratio of 9.5x forward P/E. Dive into our free research report to see why there are better opportunities than UHS. Market Cap: $512.5 million With roots dating back to 1882 and operations spanning approximately 80 countries, Owens & Minor (NYSE:OMI) is a healthcare solutions company that manufactures medical supplies, distributes products to healthcare providers, and delivers medical equipment directly to patients. Why Does OMI Give Us Pause? Scale is a double-edged sword because it limits the company's growth potential compared to its smaller competitors, as reflected in its below-average annual revenue increases of 3.2% for the last two years Underwhelming 3.8% return on capital reflects management's difficulties in finding profitable growth opportunities, and its falling returns suggest its earlier profit pools are drying up Diminishing returns on capital from an already low starting point show that neither management's prior nor current bets are going as planned Owens & Minor is trading at $6.67 per share, or 3.7x forward P/E. If you're considering OMI for your portfolio, see our FREE research report to learn more. Market Cap: $132.8 billion With roots dating back to 1849 when two German immigrants opened a fine chemicals business in Brooklyn, Pfizer (NYSE:PFE) is a global biopharmaceutical company that discovers, develops, manufactures, and sells medicines and vaccines for a wide range of diseases and conditions. Why Are We Cautious About PFE? Core business is underperforming as its organic revenue has disappointed over the past two years, suggesting it might need acquisitions to stimulate growth Free cash flow margin shrank by 8.9 percentage points over the last five years, suggesting the company is consuming more capital to stay competitive Diminishing returns on capital suggest its earlier profit pools are drying up At $23.40 per share, Pfizer trades at 7.8x forward P/E. To fully understand why you should be careful with PFE, check out our full research report (it's free). Donald Trump's victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs. While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today for free.
Yahoo
15 hours ago
- Yahoo
Universal Health Services Stock Sinks as CFO Says Post-Covid Care Recovery Has Slowed
Universal Health Services shares declined on Monday after the hospital company's CFO said the volume of care people are seeking has declined. After surging coming out of the pandemic, voluntary and surgical procedure volume is down, CFO Steve Filton said. The company expects its acute care business to return to its pre-COVID profit margins in the next 18 to 24 Health Services (UHS) shares sank after the hospital operator's CFO made comments at an industry conference about the company's outlook for volume of care it provides. Shares of UHS were down nearly 6% in Monday-afternoon trading. CFO Steve Filton said at a conference that the company and other healthcare competitors have seen "somewhat softer procedural or surgical volumes" in recent quarters, according to a transcript provided by AlphaSense. Coming out of the pandemic, companies like UHS saw a boom in voluntary procedures as Americans got caught up on care they may have put off, Filton said. Now, however, that volume of care has slowed, with Filton saying it has been "slower to recover back to historical levels than than we might have imagined and expected." Revenue has stayed stable for UHS because they have raised prices to offset the lower volume of care people are seeking, but Filton said the company thinks the variables of price and procedural volume will get closer to historical averages over time. The CFO said the company expects margins in its acute care business to return to pre-pandemic levels over the next 18 to 24 months. Read the original article on Investopedia Sign in to access your portfolio
